Home / TORNTPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TORNTPHARM.NS make money? Does TORNTPHARM.NS have pricing power? What's the Earnings Whisper? Will TORNTPHARM.NS profit more as the business scales? What is TORNTPHARM.NS's management track record? Is TORNTPHARM.NS's current price justified?

Torrent Pharmaceuticals Limited

₹4558.9 +$710.50 (+18.46%)

NSE · 16 Oct 2026 09:59 UTC

Previous Close

₹4584.1

Day Range

₹4550.4₹4618.9

Year Range

₹3532.6₹5250

Market Cap

1.73T

AVG Volume

507.15K

Trailing/Forward PE

70.75/48.73

PEG ratio

-20.15

Dividend Yield

0.83%

Next Earnings Date

2026-10-23

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

TORNTPHARM.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	49.21B
26 Q4	41.97B
26 Q3	32.51B
26 Q2	32.46B
26 Q1	31.28B
25 Q4	29.09B
25 Q3	27.62B
25 Q2	28.31B
25 Q1	28.15B
24 Q4	26.95B

Net Income (INR) · Q

TORNTPHARM.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	5.66B
26 Q4	3.89B
26 Q3	6.35B
26 Q2	5.91B
26 Q1	5.48B
25 Q4	4.98B
25 Q3	5.03B
25 Q2	4.53B
25 Q1	4.57B
24 Q4	4.49B

Operating Income (INR) · Q

TORNTPHARM.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	10.52B
26 Q4	8.48B
26 Q3	8.82B
26 Q2	8.79B
26 Q1	8.31B
25 Q4	7.63B
25 Q3	7.15B
25 Q2	7.41B
25 Q1	7.07B
24 Q4	6.92B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Torrent Pharmaceuticals Limited

Video analysis: TORNTPHARM.NS

News: TORNTPHARM.NS

Similar companies